Efficacy and Safety of Lucitanib in Advanced Thymic Carcinoma: A Randomized Phase II Trial.
Fang W, Zhou C, Wang C, Wu K, Fu J, Lin X, Zhang H, Chen J, Zhang P, Zhang Y, Tang P, Zheng Y, Liu Y, Zhi X, Gao Z, Fan Q, Cai H, Li F, Guo X, Zhang B, Mu R, Yu Z
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.